Literature DB >> 17553940

Calcium regulation of endothelin-1 synthesis in rat inner medullary collecting duct.

Kevin A Strait1, Peter K Stricklett, Jessica L Kohan, Margaux B Miller, Donald E Kohan.   

Abstract

Collecting duct-derived endothelin-1 (ET-1) reduces blood pressure and inhibits Na and water reabsorption. Collecting duct ET-1 production is increased by volume expansion; however, the mechanism by which this occurs is unknown. We hypothesized that intracellular calcium, which is likely to be increased by volume expansion, regulates collecting duct ET-1 synthesis. Rat inner medullary collecting ducts (IMCD) were studied in primary culture. ET-1 release was decreased by 50-70% after chelation of intracellular calcium (BAPTA) or inhibition of CaM (W7) or CaMK (KN-93). These agents reduced ET-1 mRNA to a similar degree. CaM inhibition did not affect ET-1 mRNA stability. Transfection of IMCD with rat ET-1 promoter-luciferase constructs revealed maximal activity within 1.7 kb 5' to the transcription start site; 5, 20, 35, and 90% of this activity were in the 0.08-, 0.37-, 1.0-, and 3.0-kb promoter regions, respectively. W7 markedly inhibited activity of the 3.0-kb but not 0.37- or 1.0-kb promoter regions. In contrast, W7 did not affect ET-1 release by rat aortic endothelial cells. Furthermore, transfected endothelial cells had maximal activity in the 0.37-kb region (as compared with the 1.7- and 3.0-kb regions), whereas W-7 had no effect on the activity of any of these promoter regions. In summary, IMCD ET-1 synthesis is regulated by calcium/CaM/CaMK-dependent pathways. The calcium/CaM-sensitive pathway is active in IMCD, but not endothelial cells. This suggests that IMCD-specific enhancer elements exist within the ET-1 promoter that confer unique calcium responsiveness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553940     DOI: 10.1152/ajprenal.00085.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  20 in total

1.  Cooperative role of ETA and ETB receptors in mediating the diuretic response to intramedullary hyperosmotic NaCl infusion.

Authors:  Erika I Boesen; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-15

2.  Identification of two nuclear factor of activated T-cells (NFAT)-response elements in the 5'-upstream regulatory region of the ET-1 promoter.

Authors:  Kevin A Strait; Peter K Stricklett; Rachel M Kohan; Donald E Kohan
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

3.  Endothelin-1 inhibits the epithelial Na+ channel through betaPix/14-3-3/Nedd4-2.

Authors:  Tengis S Pavlov; Ahmed Chahdi; Daria V Ilatovskaya; Vladislav Levchenko; Alain Vandewalle; Oleh Pochynyuk; Andrey Sorokin; Alexander Staruschenko
Journal:  J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 10.121

Review 4.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

5.  Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse.

Authors:  Kevin A Strait; Peter K Stricklett; Mark Chapman; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-02

Review 6.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

7.  Flow regulation of endothelin-1 production in the inner medullary collecting duct.

Authors:  Meghana M Pandit; Edward W Inscho; Shali Zhang; Tsugio Seki; Rajeev Rohatgi; Luca Gusella; Bellamkonda Kishore; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

8.  P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.

Authors:  Yue Zhang; Janos Peti-Peterdi; Christa E Müller; Noel G Carlson; Younis Baqi; David L Strasburg; Kristina M Heiney; Karie Villanueva; Donald E Kohan; Bellamkonda K Kishore
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

Review 9.  Endothelin-converting enzyme-1 inhibition and renoprotection in end-stage renal disease.

Authors:  Sanjaya Kuruppu; Niwanthi W Rajapakse; A Ian Smith
Journal:  Pflugers Arch       Date:  2013-01-18       Impact factor: 3.657

Review 10.  Systemic Hypertension at High Altitude.

Authors:  Offdan Narvaez-Guerra; Karela Herrera-Enriquez; Josefina Medina-Lezama; Julio A Chirinos
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.